Added to Email Alerts

Acne

Latest News View All

Data on Safety, Effectiveness of Common Acne Drug Unreliable, Some Researchers Say

Reuters Health Information December 31, 2018
Tazarotene Gel an Option for Post-Acne Scarring

Reuters Health Information November 27, 2018
Foamix's Treatment for Common Skin Condition Meets Late-Stage Trial Goals

Reuters Health Information November 8, 2018
Behind the Pimple Video Craze

WebMD Health News October 12, 2018
Alert

FDA Approves Sarecycline for Moderate to Severe Acne

FDA Approvals October 2, 2018
Alert

FDA Clears First Tretinoin Lotion for Acne (Altreno)

FDA Approvals August 27, 2018
New Guidance on Polycystic Ovary Syndrome Aims to Improve Care, Reassure Women

Reuters Health Information August 2, 2018
Sienna Biopharma Acne Drug Fails Two Trials

Reuters Health Information July 31, 2018

View All

Perspective View All

The Year's Don't-Miss News in Contraception

Article December 27, 2018

New products, technology, and laws affecting contraception will change practice in the upcoming months.
Rosacea: 5 Things to Know

Viewpoint September 19, 2018
AAD 2018

Conference Coverage February 12, 2018
Hormonal Contraceptives and the Lesser-Known Link With Suicide Risk

Commentary December 15, 2017

View All

Journal Articles View All

Caring for Transgender and Gender-Diverse Persons

American Family Physician December 28, 2018
The Pregnant Patient: Managing Common Acute Medical Problems

American Family Physician November 30, 2018
Cushing's Disease in Older Patients

Clinical Endocrinology November 19, 2018
Multiple Myeloma Concealed by Adrenal Cushing Syndrome

Journal of Medical Case Reports October 17, 2018
When Is Teenage Plastic Surgery vs Cosmetic Surgery Okay?

Plastic and Reconstructive Surgery October 5, 2018
Incidence and Prevalence of Rosacea

The British Journal of Dermatology October 1, 2018

View All

Additional Resources

Medscape Drugs & Diseases

All material on this website is protected by copyright, Copyright © 1994-2019 by WebMD LLC. This website also contains material copyrighted by 3rd parties.